The NORVIT trial indicated that, despite effectively reducing HCY levels, folic acid and vitamin B did not lower the risk of MACCE in patients with acute MI; notably, this study actually showed a trend toward increased cardiovascular risk.
← all excerpts
Relationship between serum homocysteine levels and long-term outcomes in patients with ST-segment elevation myocardial infarction.
1
—
—